Cancer - page 4 - Publications Scientifiques

Dernière publication 30/05/2012

Anticancer Activity of Methyl-substituted Oxaliplatin Analog-

Oxaliplatin is successfully used in systemic cancer therapy. However, resistance development and severe adverse effects are limiting factors for...

Array
(
    [id_prestablog_news] => 403
    [id_shop] => 1
    [date] => 2012-05-30 00:00:00
    [date_modification] => 2024-02-09 14:15:11
    [langues] => ["1","2"]
    [actif] => 1
    [slide] => 0
    [url_redirect] => 
    [average_rating] => 
    [number_rating] => 
    [author_id] => 1
    [featured] => 0
    [prim_key] => 802
    [id_lang] => 2
    [title] => Anticancer Activity of Methyl-substituted Oxaliplatin Analog- 
    [paragraph] => Anticancer Activity of Methyl-substituted Oxaliplatin Analog. 
    [content] => 
Authors
U. Jungwirth, D.  Xanthos, J. Gojo, A.  Bytzek, W. Korner et al. 

 Lab
Medical University of Vienna, Institute of Cancer Research, Vienna, Austria.
Journal
Molecular pharmacology
Abstract
Oxaliplatin is successfully used in systemic cancer therapy. However, resistance development and severe adverse effects are limiting factors for curative cancer treatment with oxaliplatin. The purpose of this study was to comparatively investigate in vitro and in vivo anticancer properties as well as the adverse effects of two methyl-substituted enantiomerically pure oxaliplatin analogs [[(1R,2R,4R)-4-methyl-1,2-cyclohexanediamine] oxalatoplatinum(II) (KP1537), and [(1R,2R,4S)-4-methyl-1,2-cyclohexanediamine]oxalatoplatinum(II) (KP1691)] and to evaluate the impact of stereoisomerism. Although the novel oxaliplatin analogs demonstrated in multiple aspects activities comparable with those of the parental compound, several key differences were discovered. The analogs were characterized by reduced vulnerability to resistance mechanisms such as p53 mutations, reduced dependence on immunogenic cell death induction, and distinctly attenuated adverse effects including weight loss and cold hyperalgesia. Stereoisomerism of the substituted methyl group had a complex and in some aspects even contradictory impact on drug accumulation and anticancer activity both in vitro and in vivo. To summarize, methyl-substituted oxaliplatin analogs harbor improved therapeutic characteristics including significantly reduced adverse effects. Hence, they might be promising metal-based anticancer drug candidates for further (pre)clinical evaluation.
BIOSEB Instruments Used
Cold Hot Plate Test (BIO-CHP)
    [meta_description] => 
    [meta_keywords] => http://molpharm.aspetjournals.org/content/81/5/719.abstract
    [meta_title] => 
    [link_rewrite] => anticancer-activity-of-methyl-substituted-oxaliplatin-analog--
    [actif_langue] => 1
    [read] => 1111
    [count_comments] => 0
    [id] => 403
    [categories] => Array
        (
            [90] => Array
                (
                    [id_prestablog_categorie] => 90
                    [title] => Cancer
                    [link_rewrite] => Cancer
                )

            [2] => Array
                (
                    [id_prestablog_categorie] => 2
                    [title] => Publications
                    [link_rewrite] => publications
                )

            [24] => Array
                (
                    [id_prestablog_categorie] => 24
                    [title] => Thématiques transversales
                    [link_rewrite] => Thematiques-transversales
                )

            [94] => Array
                (
                    [id_prestablog_categorie] => 94
                    [title] => Toxicologie
                    [link_rewrite] => Toxicologie
                )

        )

    [authors] => 
    [paragraph_crop] => Anticancer Activity of Methyl-substituted Oxaliplatin Analog. 
    [link_for_unique] => 1
    [products_liaison] => Array
        (
            [563] => Array
                (
                    [name] => Plaque froid et chaud
                    [description_short] => 
Instrument de test de la sensibilité de l'animal à la douleur résultant de l'exposition à la chaleur ou au froid: la plaque froid et chaud de Bioseb est un instrument innovant ouvrant de nouveaux champs d'investigation pour vos recherches en analgésie et nociception, et un outil efficace pour le screening de substances analgésiques basé sur les modèles de rat ou souris.

                    [thumb] => 
                    [img_empty] => /var/www/vhosts/de3310.ispfr.net/preprod.bioseb.com/modules/prestablog/views/img/product_link_white.jpg
                    [image_presente] => 1
                    [link] => https://preprod.bioseb.com/fr/douleur-allodyniehyperalgesie-thermique/563-cold-hot-plate-test.html
                )

        )

)
1